Cardiovascular Systems is recalling certain lots of the Diamondback 360 Peripheral Orbital Atherectomy System, because they may contain defective saline sheaths that could fracture during use. If this happens, fragments of the sheath could possibly block blood vessels. The U.S. Food and Drug Administration (FDA) said as of this week, there are no reports of patient injuries to date.
 
Medical Record Software Medical Collaboration EMR PACS

Healthcare technology has evolved immensely in the past few years. With electronic medical records (EMR), medical image transfers or telemedicine, it is easy to forget that the priority is the patient — an individual person with unique needs, concerns and feelings. 

Bluegrass Vascular Technologies closed $4.5 million in Series A financing, that will allow the company to obtain CE mark for the Surfacer Inside-Out Access Catheter System. 

At the Transcatheter Cardiovascular Therapeutics (TCT) 2014 meeting Sept. 13-17, Toshiba will display newer features offered on its Infinix cardiovascular X-ray system to improve diagnostic accuracy and patient safety.

August 18, 2014 — Two Mount Sinai research studies in the August issue of the Journal of the American College of Cardiology (ACC): Cardiovascular Imaging show the potential of using tele-robotic medicine when diagnosing heart failure patients.

A clinical trial being conducted at Mission Health on a special catheter could one day help people with a persistent heart condition that does not respond to medication.

Polidocanol injectable foam (Varithena), the only U.S. Food and Drug Administration (FDA)-approved foam for the treatment of incompetent great saphenous veins (GSV), accessory saphenous veins and visible varicosities of the GSV system both above and below the knee.

HIPAA, HIPPA, cyber security concerns are rising over how to better securing patient records.

The healthcare industry is becoming more mobile and efficient than ever before thanks to the adoption of technologies such as electronic health records (EHR) and electronic sharing, storing and accessing of medical data. These advances have all helped to give patients a more dynamic and comprehensive healthcare experience. They have also helped empower patients to take control of their own healthcare history and information.    

OrbusNeich announced first patient enrollment in the Randomized Evaluation of short-term Dual anti platelet therapy in patients with acute coronary syndrome treated with the Combo Dual Therapy StEnt (REDUCE) Study. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now